Alto Neuroscience President And CFO Sold Shares Worth Over $3.5M
Nicholas Conrad Smith, an insider and President And CFO, reported sales of Alto Neuroscience common stock under a Rule 10b5-1 plan adopted June 30, 2026. The sales were made at a weighted average price of $26.5826 per share for the largest tranche and at prices of $25.7786 and $26.87 for subsequent…